Moderna, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Moderna, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
  • Moderna, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $2.22B, a 1335% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $2.22B +$2.07B +1335% Dec 31, 2023 10-K 2024-02-23
Q3 2023 $1.7B Sep 30, 2023 10-Q 2024-11-07
Q4 2022 $155M +$6M +4.03% Dec 31, 2022 10-K 2024-02-23
Q4 2021 $149M -$674M -81.9% Dec 31, 2021 10-K 2024-02-23
Q4 2020 $823M +$352M +74.7% Dec 31, 2020 10-K 2024-02-23
Q4 2019 $471M +$163M +52.9% Dec 31, 2019 10-K 2023-02-24
Q4 2018 $308M +$109M +55% Dec 31, 2018 10-K 2022-02-25
Q4 2017 $199M Dec 31, 2017 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.